Although malignant melanomas mainly have activating mutations in N-Ras and wogonin inhibited Ras protein expression, wogonin's effect on mutant forms of Ras proteins remains unclear and tumors are usually controlled by a single oncogene. The gene discussed is NRAS; the disease is melanoma.